Market Overview:
The global gene-deleted vaccines market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for gene-deleted vaccines due to their benefits over traditional vaccines. Gene-deleted vaccines are more effective as they target only the specific pathogen and do not affect other organisms in the body, which reduces the risk of side effects. In addition, these vaccines are also easier and faster to produce than traditional ones, which is another factor contributing to their growing popularity. The market for gene-deleted vaccine is segmented on the basis of type into single gene deleted vaccine and double gene deleted vaccine. The single gene deleted vaccine segment is expected to account for a larger share of the market in 2018 owing its lower production costs and higher efficacy rates as compared with double gene deleted vaccines. However, with technological advancements being made in this field, double gene deletion technology is expected overtake single deletion technology by 2030.
Product Definition:
Gene-deleted vaccines are created by deleting a gene from the virus used to make the vaccine. This makes the vaccine less likely to cause disease. Gene-deleted vaccines are important because they can protect people from diseases caused by viruses that have been modified to delete a gene.
Single Gene Deleted Vaccine:
Single gene deleted vaccine is a new concept in immunology. It was created by the scientists of Japan's National Institute of Infectious Diseases (NIID) and the University of Tokyo. The single gene that is to be deleted from the virus contains genes for coat protein, spike protein, and hemagglutinin (HA). This makes their life cycle short and they cannot survive in human body without spike & coat proteins.
Double Gene Deleted Vaccine:
Double gene deleted vaccine is a new and innovative way to prevent diseases. It's an injection that prevents the spread of HIV, HPV, and other viruses that cause AIDS or other diseases. The vaccine works by stimulating the immune system to produce more antibodies than normal.
The two genes in this vaccine are used to make a special kind of antibody called anti-DNA antibody for fighting cancer cells and bacteria.
Application Insights:
The application segment includes veterinary hospitals, clinics and animal care centers. Veterinary hospitals are expected to be the fastest-growing application segment over the forecast period owing to increasing adoption of gene-deleted vaccines in order to limit disease transmission between animals and humans. Gene-deleted vaccines have been proven effective against a wide range of diseases that affect both humans and animals. These include respiratory diseases, gastrointestinal infections, infectious bronchitis, canine influenza virus infection in dogs, paratyphoid fever among others (1).
Animal Care Centers orACCs are expected to witness significant growth over the forecast period due ACCs serve as a primary healthcare provider for pet owners who bring their pets for regular medical checkups along with boarding/grooming services at these centers.
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of a large number of companies and research institutes involved in gene editing technology, increased R&D expenditure by government agencies for disease control, high purchasing power of people and growing pet population. Moreover, increasing incidence of chronic diseases among pets has led to an increase in demand for preventive measures such as vaccination against these diseases.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as rising disposable income resulting into an increase in healthcare expenditure towards animal health care along with growing awareness about veterinary services leading toward higher adoption rates particularly among emerging economies like China & India are anticipated to drive this regional market during the forecast period from 2018-2030 (See Figure below). Furthermore, countries like Japan have a long history associated with veterinary medicine which also contributes toward driving this regional market during the forecast period from 2018-2030 (See Figure below).
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the gene-deleted vaccines market. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, and parasites. These microorganisms can cause a wide range of infections in humans, which can lead to serious health complications and even death in some cases. The increasing incidence of infectious diseases is thus driving the demand for gene-deleted vaccines that can help protect against these infections.
- Growing awareness about benefits of gene-deleted vaccines: There is a growing awareness about the benefits of using gene-deleted vaccines among healthcare professionals and patients alike. This is helping to drive demand for these vaccines worldwide.
- Technological advancements in vaccine development: The technological advancements in vaccine development are helping to drive growth for the global gene-deleted vaccines market . These advancements are resulting in the introduction of novel and more effective vaccine formulations that offer better protection against various infections caused by pathogens. This is aiding in boosting demand for gene-deleted vaccines globally .
Scope Of The Report
Report Attributes
Report Details
Report Title
Gene-Deleted Vaccines Market Research Report
By Type
Single Gene Deleted Vaccine, Double Gene Deleted Vaccine
By Application
Veterinary Hospitals, Veterinary Clinics, Animal Care Centers, Others
By Companies
Virbac SA, Merck Animal Health, Zoetis Inc, Boehringer Ingelheim GmbH, Ceva, Bayer, Biogenesis-Bago, Indian Immunologicals Ltd, Heska Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
190
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Gene-Deleted Vaccines Market Report Segments:
The global Gene-Deleted Vaccines market is segmented on the basis of:
Types
Single Gene Deleted Vaccine, Double Gene Deleted Vaccine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Veterinary Hospitals, Veterinary Clinics, Animal Care Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Virbac SA
- Merck Animal Health
- Zoetis Inc
- Boehringer Ingelheim GmbH
- Ceva
- Bayer
- Biogenesis-Bago
- Indian Immunologicals Ltd
- Heska Corporation
Highlights of The Gene-Deleted Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Gene Deleted Vaccine
- Double Gene Deleted Vaccine
- By Application:
- Veterinary Hospitals
- Veterinary Clinics
- Animal Care Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gene-Deleted Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gene-deleted vaccines are vaccines that use genetic engineering to remove specific genes from the virus or bacteria used in the vaccine. This process makes it easier for the body to fight off the disease, as fewer proteins are present on which the immune system can build an immunity.
Some of the major players in the gene-deleted vaccines market are Virbac SA, Merck Animal Health, Zoetis Inc, Boehringer Ingelheim GmbH, Ceva, Bayer, Biogenesis-Bago, Indian Immunologicals Ltd, Heska Corporation.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gene-Deleted Vaccines Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gene-Deleted Vaccines Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gene-Deleted Vaccines Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gene-Deleted Vaccines Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gene-Deleted Vaccines Market Size & Forecast, 2018-2028
4.5.1 Gene-Deleted Vaccines Market Size and Y-o-Y Growth
4.5.2 Gene-Deleted Vaccines Market Absolute $ Opportunity
Chapter 5 Global Gene-Deleted Vaccines Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Gene-Deleted Vaccines Market Size Forecast by Type
5.2.1 Single Gene Deleted Vaccine
5.2.2 Double Gene Deleted Vaccine
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Gene-Deleted Vaccines Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Gene-Deleted Vaccines Market Size Forecast by Applications
6.2.1 Veterinary Hospitals
6.2.2 Veterinary Clinics
6.2.3 Animal Care Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gene-Deleted Vaccines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gene-Deleted Vaccines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Gene-Deleted Vaccines Analysis and Forecast
9.1 Introduction
9.2 North America Gene-Deleted Vaccines Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Gene-Deleted Vaccines Market Size Forecast by Type
9.6.1 Single Gene Deleted Vaccine
9.6.2 Double Gene Deleted Vaccine
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Gene-Deleted Vaccines Market Size Forecast by Applications
9.10.1 Veterinary Hospitals
9.10.2 Veterinary Clinics
9.10.3 Animal Care Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Gene-Deleted Vaccines Analysis and Forecast
10.1 Introduction
10.2 Europe Gene-Deleted Vaccines Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Gene-Deleted Vaccines Market Size Forecast by Type
10.6.1 Single Gene Deleted Vaccine
10.6.2 Double Gene Deleted Vaccine
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Gene-Deleted Vaccines Market Size Forecast by Applications
10.10.1 Veterinary Hospitals
10.10.2 Veterinary Clinics
10.10.3 Animal Care Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Gene-Deleted Vaccines Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Gene-Deleted Vaccines Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Gene-Deleted Vaccines Market Size Forecast by Type
11.6.1 Single Gene Deleted Vaccine
11.6.2 Double Gene Deleted Vaccine
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Gene-Deleted Vaccines Market Size Forecast by Applications
11.10.1 Veterinary Hospitals
11.10.2 Veterinary Clinics
11.10.3 Animal Care Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Gene-Deleted Vaccines Analysis and Forecast
12.1 Introduction
12.2 Latin America Gene-Deleted Vaccines Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Gene-Deleted Vaccines Market Size Forecast by Type
12.6.1 Single Gene Deleted Vaccine
12.6.2 Double Gene Deleted Vaccine
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Gene-Deleted Vaccines Market Size Forecast by Applications
12.10.1 Veterinary Hospitals
12.10.2 Veterinary Clinics
12.10.3 Animal Care Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Gene-Deleted Vaccines Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Gene-Deleted Vaccines Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Gene-Deleted Vaccines Market Size Forecast by Type
13.6.1 Single Gene Deleted Vaccine
13.6.2 Double Gene Deleted Vaccine
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Gene-Deleted Vaccines Market Size Forecast by Applications
13.10.1 Veterinary Hospitals
13.10.2 Veterinary Clinics
13.10.3 Animal Care Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gene-Deleted Vaccines Market: Competitive Dashboard
14.2 Global Gene-Deleted Vaccines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Virbac SA
14.3.2 Merck Animal Health
14.3.3 Zoetis Inc
14.3.4 Boehringer Ingelheim GmbH
14.3.5 Ceva
14.3.6 Bayer
14.3.7 Biogenesis-Bago
14.3.8 Indian Immunologicals Ltd
14.3.9 Heska Corporation
